Industries > Pharma > Periodontal Therapeutics Market Report 2021-2031
Periodontal Therapeutics Market Report 2021-2031
By Product (Systemic Antibiotics, and Local Antibiotics), By Type (Gingivitis, Chronic Periodontitis, Aggressive Periodontitis, and Necrotizing Periodontal Disease), By Drug Type (Generic, and Branded), By Patient Demographics (Adults, Geriatric, Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Leading Regional/ Country market analysis
Periodontal Therapeutics Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Periodontal Therapeutics is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 290+ page report provides 380+ tables and 370+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Periodontal Therapeutics Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Periodontal Therapeutics Market By Product
• Systemic Antibiotics
o Doxycycline
o Minocycline
o Metronidazole
o Others
• Local Antibiotics
o Arestin
o Periochip
o Atridox
o Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Periodontal Therapeutics Market By Type
• Gingivitis
• Chronic Periodontitis
• Aggressive Periodontitis
• Necrotizing Periodontal Disease
• Revenue and growth forecasts from 2021 to 2031 for the Global Periodontal Therapeutics Market By Drug Type
• Generic
• Branded
• Revenue and growth forecasts from 2021 to 2031 for the Global Periodontal Therapeutics Market By Patient Demographics
• Adults
• Geriatric
• Pediatric
• Revenue and growth forecasts from 2021 to 2031 for the Global Periodontal Therapeutics Market By End User
• Hospitals
• Homecare
• Specialty Clinics
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Periodontal Therapeutics Market By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Periodontal Therapeutics Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Periodontal Therapeutics Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Periodontal Therapeutics Market report helps you
In summary, our 290+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Periodontal Therapeutics Market, with forecasts for Get our report today Periodontal Therapeutics Market Forecast 2021-2031: By Product, Type, Drug Type, Patient Demographics, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Periodontal Therapeutics market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Periodontal Therapeutics Market. Some of the company’s profiled in this report include
• Den-Mat Holdings, LLC
• Valeant Pharmaceuticals International, Inc.
• Dexcel Pharma
• 3M Company
• Oral Science
• Kaken Pharmaceutical Co., Ltd.
• Galderma S.A.
• OASIS Medical
• AFT Pharmaceuticals
• I-Med Pharma Inc.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Periodontal Therapeutics Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Periodontal Therapeutics Market Report 2021-2031: By Product (Systemic Antibiotics, and Local Antibiotics), By Type (Gingivitis, Chronic Periodontitis, Aggressive Periodontitis, and Necrotizing Periodontal Disease), By Drug Type (Generic, and Branded), By Patient Demographics (Adults, Geriatric, Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Leading Regional/ Country market analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Periodontal Therapeutics Market
2.1. Periodontal Therapeutics Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Periodontal Therapeutics Market Overview
3.1. Global Periodontal Therapeutics Market Size and Forecast By Region
3.2. Global Periodontal Therapeutics Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Prevalence of Periodontal Diseases around the World
3.3.1.2. Increasing research and development for Periodontal Therapeutics
3.3.1.3. Increasing Strategic initiatives in Periodontal Therapeutics market
3.3.1.4. Increasing awareness in emerging nations
3.3.2. Market Restraints
3.3.2.1. Stringent Regulation associated with product development
3.3.2.2. High Cost of development
3.3.2.3. Unmet medical needs
3.3.3. Opportunities
3.3.3.1. Increasing therapeutic Advancements in Periodontal Therapeutics
3.3.3.2. Growing awareness regarding Periodontal Disease
3.3.4. Challenges
3.3.4.1. Increase in number of competitor in the market
3.3.4.2. Side effects associated with the therapeutics
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Periodontal Therapeutics Market Analysis and Forecast 2021-2031, By Product (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Systemic Antibiotics
4.1.1.1. Systemic Antibiotics market size and forecast, 2021-2031 (USD Million)
4.1.2. Local Antibiotics
4.1.2.1. Local Antibiotics market size and forecast, 2021-2031 (USD Million)
5. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Gingivitis
5.1.1.1. Gingivitis market size and forecast, 2021-2031 (USD Million)
5.1.2. Chronic Periodontitis
5.1.2.1. Chronic Periodontitis market size and forecast, 2021-2031 (USD Million)
5.1.3. Aggressive Periodontitis
5.1.3.1. Aggressive Periodontitis market size and forecast, 2021-2031 (USD Million)
5.1.4. Necrotizing Periodontal Disease
5.1.4.1. Necrotizing Periodontal Disease market size and forecast, 2021-2031 (USD Million)
6. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By Patient Demographics (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Geriatric
6.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
6.1.2. Adults
6.1.2.1. Adults market size and forecast, 2021-2031 (USD Million)
6.1.3. Pediatric
6.1.3.1. Pediatric market size and forecast, 2021-2031 (USD Million)
7. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By Drug Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Generic
7.1.1.1. Generic market size and forecast, 2021-2031 (USD Million)
7.1.2. Branded
7.1.2.1. Branded market size and forecast, 2021-2031 (USD Million)
8. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospitals
8.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
8.1.2. Homecare
8.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
8.1.3. Specialty Clinics
8.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
8.1.4. Others
8.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
9. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.1.1. Hospitals Pharmacy
9.1.1.1. Hospitals Pharmacy market size and forecast, 2021-2031 (USD Million)
9.1.2. Retail Pharmacy
9.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
9.1.3. Online Pharmacies
9.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
10. North America Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. North America Periodontal Therapeutics Market Size and Forecast By Product
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. North America Periodontal Therapeutics Market Size and Forecast By Drug Type
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. North America Periodontal Therapeutics Market Size and Forecast By Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. North America Periodontal Therapeutics Market Size and Forecast By Patient Demographics
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. North America Periodontal Therapeutics Market Size and Forecast By End-User
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. North America Periodontal Therapeutics Market Size and Forecast By Distribution Channel
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. U.S. Periodontal Therapeutics Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. Canada Periodontal Therapeutics Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
11. Europe Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Europe Periodontal Therapeutics Market Size and Forecast By Product
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Europe Periodontal Therapeutics Market Size and Forecast By Patient Demographics
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Europe Periodontal Therapeutics Market Size and Forecast By Drug Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Europe Periodontal Therapeutics Market Size and Forecast By Type
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Europe Periodontal Therapeutics Market Size and Forecast By End-User
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. Europe Periodontal Therapeutics Market Size and Forecast By Distribution Channel
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. UK Periodontal Therapeutics Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Germany Periodontal Therapeutics Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. France Periodontal Therapeutics Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
11.11. Rest of Europe Periodontal Therapeutics Market
11.11.1.1. XX Driving/Opportunity Factor
11.11.1.2. XX Driving/Opportunity Factor
12. Asia Pacific Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Product
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Patient Demographics
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Drug Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Type
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By End-User
12.6.1.1. XX Driving/Opportunity Factor
12.6.1.2. XX Driving/Opportunity Factor
12.7. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Distribution Channel
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. China Periodontal Therapeutics Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. India Periodontal Therapeutics Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
12.10. Japan Periodontal Therapeutics Market
12.10.1.1. XX Driving/Opportunity Factor
12.10.1.2. XX Driving/Opportunity Factor
12.11. Rest of Asia Pacific Periodontal Therapeutics Market
12.11.1.1. XX Driving/Opportunity Factor
12.11.1.2. XX Driving/Opportunity Factor
13. Latin America Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. Latin America Periodontal Therapeutics Market Size and Forecast By Product
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. Latin America Periodontal Therapeutics Market Size and Forecast By Patient Demographics
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. Latin America Periodontal Therapeutics Market Size and Forecast By Drug Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. Latin America Periodontal Therapeutics Market Size and Forecast By Type
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. Latin America Periodontal Therapeutics Market Size and Forecast By End-User
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. Latin America Periodontal Therapeutics Market Size and Forecast By Distribution Channel
13.8. Brazil Periodontal Therapeutics Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Mexico Periodontal Therapeutics Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
13.10. Rest of Latin America Periodontal Therapeutics Market
13.10.1.1. XX Driving/Opportunity Factor
13.10.1.2. XX Driving/Opportunity Factor
14. MEA Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
14.1. Market Overview
14.2. MEA Periodontal Therapeutics Market Size and Forecast By Product
14.2.1.1. XX Driving/Opportunity Factor
14.2.1.2. XX Driving/Opportunity Factor
14.3. MEA Periodontal Therapeutics Market Size and Forecast By Patient Demographics
14.3.1.1. XX Driving/Opportunity Factor
14.3.1.2. XX Driving/Opportunity Factor
14.4. MEA Periodontal Therapeutics Market Size and Forecast By Drug Type
14.4.1.1. XX Driving/Opportunity Factor
14.4.1.2. XX Driving/Opportunity Factor
14.5. MEA Periodontal Therapeutics Market Size and Forecast By Type
14.5.1.1. XX Driving/Opportunity Factor
14.5.1.2. XX Driving/Opportunity Factor
14.6. MEA Periodontal Therapeutics Market Size and Forecast By End-User
14.6.1.1. XX Driving/Opportunity Factor
14.6.1.2. XX Driving/Opportunity Factor
14.7. MEA Periodontal Therapeutics Market Size and Forecast By Distribution Channel
14.7.1.1. XX Driving/Opportunity Factor
14.7.1.2. XX Driving/Opportunity Factor
14.8. GCC Periodontal Therapeutics Market
14.8.1.1. XX Driving/Opportunity Factor
14.8.1.2. XX Driving/Opportunity Factor
14.9. South Africa Periodontal Therapeutics Market
14.9.1.1. XX Driving/Opportunity Factor
14.9.1.2. XX Driving/Opportunity Factor
14.10. Rest of MEA Periodontal Therapeutics Market
14.10.1.1. XX Driving/Opportunity Factor
14.10.1.2. XX Driving/Opportunity Factor
15. Companies in the Periodontal Therapeutics Market
15.1. Den-Mat Holdings, LLC
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Performance (2015-2019)
15.1.3.1. Net Revenue
15.1.3.2. Gross Profit
15.1.3.3. Geographical Revenue, 2019
15.1.4. Product Offerings
15.1.5. Recent Initiatives (2017-2019)
15.2. Valeant Pharmaceuticals International, Inc.
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Performance (2015-2019)
15.2.3.1. Net Revenue
15.2.3.2. Gross Profit
15.2.3.3. Geographical Revenue, 2019
15.2.4. Product Offerings
15.2.5. Recent Initiatives (2017-2019)
15.3. DEXCEL PHARMA
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Performance (2015-2019)
15.3.3.1. Net Revenue
15.3.3.2. Gross Profit
15.3.3.3. Geographical Revenue, 2019
15.3.4. Product Offerings
15.3.5. Recent Initiatives (2017-2019)
15.4. 3M Company
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Performance (2015-2019)
15.4.3.1. Net Revenue
15.4.3.2. Gross Profit
15.4.3.3. Geographical Revenue, 2019
15.4.4. Product Offerings
15.4.5. Recent Initiatives (2017-2019)
15.5. Oral Science
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Performance (2015-2019)
15.5.3.1. Net Revenue
15.5.3.2. Gross Profit
15.5.3.3. Geographical Revenue, 2019
15.5.4. Product Offerings
15.5.5. Recent Initiatives (2017-2019)
15.6. Kaken Pharmaceutical Co., Ltd.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Performance (2015-2019)
15.6.3.1. Net Revenue
15.6.3.2. Gross Profit
15.6.3.3. Geographical Revenue, 2019
15.6.4. Product Offerings
15.6.5. Recent Initiatives (2017-2019)
15.7. Galderma S.A.
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Performance (2015-2019)
15.7.3.1. Net Revenue
15.7.3.2. Gross Profit
15.7.3.3. Geographical Revenue, 2019
15.7.4. Product Offerings
15.7.5. Recent Initiatives (2017-2019)
15.8. OASIS Medical
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Performance (2015-2019)
15.8.3.1. Net Revenue
15.8.3.2. Gross Profit
15.8.3.3. Geographical Revenue, 2019
15.8.4. Product Offerings
15.8.5. Recent Initiatives (2017-2019)
15.9. AFT Pharmaceuticals
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Performance (2015-2019)
15.9.3.1. Net Revenue
15.9.3.2. Gross Profit
15.9.3.3. Geographical Revenue, 2019
15.9.4. Product Offerings
15.9.5. Recent Initiatives (2017-2019)
15.10. I-Med Pharma Inc.
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Performance (2015-2019)
15.10.3.1. Net Revenue
15.10.3.2. Gross Profit
15.10.3.3. Geographical Revenue, 2019
15.10.4. Product Offerings
15.10.5. Recent Initiatives (2017-2019)
15.11. Other Notable Players
16. Conclusion
17. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Periodontal Therapeutics Market Drivers & Restraints 2021
Table 7. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 173. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Leading 10 Periodontal Therapeutics Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 372. Den-Mat Holdings, LLCProfile 2019 (CEO, HQ, Founded, Website)
Table 373. Den-Mat Holdings, LLC Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 374. Valeant Pharmaceuticals International, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 375. Valeant Pharmaceuticals International, Inc. Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 376. DEXCEL PHARMA Profile 2019 (CEO, HQ, Founded, Website)
Table 377. DEXCEL PHARMA.Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 378. 3M Company Profile 2019 (CEO, HQ, Founded, Website)
Table 379. 3M Company Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 380. Oral Science Profile 2019 (CEO, HQ, Founded, Website)
Table 381. Oral Science Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 382. Kaken Pharmaceutical Co., Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 383. Kaken Pharmaceutical Co., Ltd. Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 384. Galderma S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 385. Galderma S.A. Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 386. OASIS Medical Profile 2019 (CEO, HQ, Founded, Website)
Table 387. OASIS Medical Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 388. AFT Pharmaceuticals Profile 2019 (CEO, HQ, Founded, Website)
Table 389. AFT Pharmaceuticals Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 390. I-Med Pharma Inc. Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 391. I-Med Pharma Inc. Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 392. Other Companies Involved in the Periodontal Therapeutics Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Periodontal Therapeutics Market Drivers & Restraints 2021
Figure 7. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 138. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 143. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 173. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 207. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 212. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Porter’s Five Force Analysis
Companies Mentioned
1. AbbVie
2. Achaogen
3. Actavis
4. Actelion
5. Affinium Pharmaceutical
6. AiCuris GmbH & Co. KG
7. Alcon
8. Alkem Laboratories
9. Dexcel Pharma
10. Allied Pharma
11. Apotex
12. APP Pharmaceuticals
13. Aptalis Pharma
14. Aquapharm Biodiscovery
15. Cempra Pharmaceuticals
16. Cipla
17. Claris Lifesciences
18. Cornerstone Biopharma
19. Cornerstone Therapeutics
20. Corona Remedies
21. Eli Lilly
22. Gate Pharma
23. Gilead Sciences
24. GlaxoSmithKline (GSK)
25. Glenmark
26. GlycoVaxyn
27. Hetero
28. Hikma Farmaceutica
29. Hi-Tech Pharma
30. Hospira
31. Macleod Pharmaceuticals
32. Microlabs
33. Nalneva
34. Novartis
35. Novexel
36. Paratek Pharmaceuticals
37. Pfizer
38. Ranbaxy
39. Roche
40. Sagent Pharmaceuticals
41. Sandoz
42. Sanofi
43. Sequella
44. Shanghai MengKe Pharmaceuticals
45. Shionogi
46. SHIONOGI Co., Ltd.
47. Shire
48. Sidmak Labs
49. Solitaire Pharmacia
50. Specialised Therapeutics Australia
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Periodontal Therapeutics Market
2.1. Periodontal Therapeutics Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Periodontal Therapeutics Market Overview
3.1. Global Periodontal Therapeutics Market Size and Forecast By Region
3.2. Global Periodontal Therapeutics Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Prevalence of Periodontal Diseases around the World
3.3.1.2. Increasing research and development for Periodontal Therapeutics
3.3.1.3. Increasing Strategic initiatives in Periodontal Therapeutics market
3.3.1.4. Increasing awareness in emerging nations
3.3.2. Market Restraints
3.3.2.1. Stringent Regulation associated with product development
3.3.2.2. High Cost of development
3.3.2.3. Unmet medical needs
3.3.3. Opportunities
3.3.3.1. Increasing therapeutic Advancements in Periodontal Therapeutics
3.3.3.2. Growing awareness regarding Periodontal Disease
3.3.4. Challenges
3.3.4.1. Increase in number of competitor in the market
3.3.4.2. Side effects associated with the therapeutics
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Periodontal Therapeutics Market Analysis and Forecast 2021-2031, By Product (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Systemic Antibiotics
4.1.1.1. Systemic Antibiotics market size and forecast, 2021-2031 (USD Million)
4.1.2. Local Antibiotics
4.1.2.1. Local Antibiotics market size and forecast, 2021-2031 (USD Million)
5. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Gingivitis
5.1.1.1. Gingivitis market size and forecast, 2021-2031 (USD Million)
5.1.2. Chronic Periodontitis
5.1.2.1. Chronic Periodontitis market size and forecast, 2021-2031 (USD Million)
5.1.3. Aggressive Periodontitis
5.1.3.1. Aggressive Periodontitis market size and forecast, 2021-2031 (USD Million)
5.1.4. Necrotizing Periodontal Disease
5.1.4.1. Necrotizing Periodontal Disease market size and forecast, 2021-2031 (USD Million)
6. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By Patient Demographics (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Geriatric
6.1.1.1. Geriatric market size and forecast, 2021-2031 (USD Million)
6.1.2. Adults
6.1.2.1. Adults market size and forecast, 2021-2031 (USD Million)
6.1.3. Pediatric
6.1.3.1. Pediatric market size and forecast, 2021-2031 (USD Million)
7. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By Drug Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Generic
7.1.1.1. Generic market size and forecast, 2021-2031 (USD Million)
7.1.2. Branded
7.1.2.1. Branded market size and forecast, 2021-2031 (USD Million)
8. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospitals
8.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
8.1.2. Homecare
8.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
8.1.3. Specialty Clinics
8.1.3.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
8.1.4. Others
8.1.4.1. Others market size and forecast, 2021-2031 (USD Million)
9. Global Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.1.1. Hospitals Pharmacy
9.1.1.1. Hospitals Pharmacy market size and forecast, 2021-2031 (USD Million)
9.1.2. Retail Pharmacy
9.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
9.1.3. Online Pharmacies
9.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
10. North America Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. North America Periodontal Therapeutics Market Size and Forecast By Product
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. North America Periodontal Therapeutics Market Size and Forecast By Drug Type
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. North America Periodontal Therapeutics Market Size and Forecast By Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. North America Periodontal Therapeutics Market Size and Forecast By Patient Demographics
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. North America Periodontal Therapeutics Market Size and Forecast By End-User
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. North America Periodontal Therapeutics Market Size and Forecast By Distribution Channel
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. U.S. Periodontal Therapeutics Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. Canada Periodontal Therapeutics Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
11. Europe Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Europe Periodontal Therapeutics Market Size and Forecast By Product
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Europe Periodontal Therapeutics Market Size and Forecast By Patient Demographics
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Europe Periodontal Therapeutics Market Size and Forecast By Drug Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Europe Periodontal Therapeutics Market Size and Forecast By Type
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Europe Periodontal Therapeutics Market Size and Forecast By End-User
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. Europe Periodontal Therapeutics Market Size and Forecast By Distribution Channel
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. UK Periodontal Therapeutics Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Germany Periodontal Therapeutics Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. France Periodontal Therapeutics Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
11.11. Rest of Europe Periodontal Therapeutics Market
11.11.1.1. XX Driving/Opportunity Factor
11.11.1.2. XX Driving/Opportunity Factor
12. Asia Pacific Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Product
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Patient Demographics
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Drug Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Type
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By End-User
12.6.1.1. XX Driving/Opportunity Factor
12.6.1.2. XX Driving/Opportunity Factor
12.7. Asia-Pacific Periodontal Therapeutics Market Size and Forecast By Distribution Channel
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. China Periodontal Therapeutics Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. India Periodontal Therapeutics Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
12.10. Japan Periodontal Therapeutics Market
12.10.1.1. XX Driving/Opportunity Factor
12.10.1.2. XX Driving/Opportunity Factor
12.11. Rest of Asia Pacific Periodontal Therapeutics Market
12.11.1.1. XX Driving/Opportunity Factor
12.11.1.2. XX Driving/Opportunity Factor
13. Latin America Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. Latin America Periodontal Therapeutics Market Size and Forecast By Product
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. Latin America Periodontal Therapeutics Market Size and Forecast By Patient Demographics
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. Latin America Periodontal Therapeutics Market Size and Forecast By Drug Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. Latin America Periodontal Therapeutics Market Size and Forecast By Type
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. Latin America Periodontal Therapeutics Market Size and Forecast By End-User
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. Latin America Periodontal Therapeutics Market Size and Forecast By Distribution Channel
13.8. Brazil Periodontal Therapeutics Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Mexico Periodontal Therapeutics Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
13.10. Rest of Latin America Periodontal Therapeutics Market
13.10.1.1. XX Driving/Opportunity Factor
13.10.1.2. XX Driving/Opportunity Factor
14. MEA Periodontal Therapeutics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
14.1. Market Overview
14.2. MEA Periodontal Therapeutics Market Size and Forecast By Product
14.2.1.1. XX Driving/Opportunity Factor
14.2.1.2. XX Driving/Opportunity Factor
14.3. MEA Periodontal Therapeutics Market Size and Forecast By Patient Demographics
14.3.1.1. XX Driving/Opportunity Factor
14.3.1.2. XX Driving/Opportunity Factor
14.4. MEA Periodontal Therapeutics Market Size and Forecast By Drug Type
14.4.1.1. XX Driving/Opportunity Factor
14.4.1.2. XX Driving/Opportunity Factor
14.5. MEA Periodontal Therapeutics Market Size and Forecast By Type
14.5.1.1. XX Driving/Opportunity Factor
14.5.1.2. XX Driving/Opportunity Factor
14.6. MEA Periodontal Therapeutics Market Size and Forecast By End-User
14.6.1.1. XX Driving/Opportunity Factor
14.6.1.2. XX Driving/Opportunity Factor
14.7. MEA Periodontal Therapeutics Market Size and Forecast By Distribution Channel
14.7.1.1. XX Driving/Opportunity Factor
14.7.1.2. XX Driving/Opportunity Factor
14.8. GCC Periodontal Therapeutics Market
14.8.1.1. XX Driving/Opportunity Factor
14.8.1.2. XX Driving/Opportunity Factor
14.9. South Africa Periodontal Therapeutics Market
14.9.1.1. XX Driving/Opportunity Factor
14.9.1.2. XX Driving/Opportunity Factor
14.10. Rest of MEA Periodontal Therapeutics Market
14.10.1.1. XX Driving/Opportunity Factor
14.10.1.2. XX Driving/Opportunity Factor
15. Companies in the Periodontal Therapeutics Market
15.1. Den-Mat Holdings, LLC
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Performance (2015-2019)
15.1.3.1. Net Revenue
15.1.3.2. Gross Profit
15.1.3.3. Geographical Revenue, 2019
15.1.4. Product Offerings
15.1.5. Recent Initiatives (2017-2019)
15.2. Valeant Pharmaceuticals International, Inc.
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Performance (2015-2019)
15.2.3.1. Net Revenue
15.2.3.2. Gross Profit
15.2.3.3. Geographical Revenue, 2019
15.2.4. Product Offerings
15.2.5. Recent Initiatives (2017-2019)
15.3. DEXCEL PHARMA
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Performance (2015-2019)
15.3.3.1. Net Revenue
15.3.3.2. Gross Profit
15.3.3.3. Geographical Revenue, 2019
15.3.4. Product Offerings
15.3.5. Recent Initiatives (2017-2019)
15.4. 3M Company
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Performance (2015-2019)
15.4.3.1. Net Revenue
15.4.3.2. Gross Profit
15.4.3.3. Geographical Revenue, 2019
15.4.4. Product Offerings
15.4.5. Recent Initiatives (2017-2019)
15.5. Oral Science
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Performance (2015-2019)
15.5.3.1. Net Revenue
15.5.3.2. Gross Profit
15.5.3.3. Geographical Revenue, 2019
15.5.4. Product Offerings
15.5.5. Recent Initiatives (2017-2019)
15.6. Kaken Pharmaceutical Co., Ltd.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Performance (2015-2019)
15.6.3.1. Net Revenue
15.6.3.2. Gross Profit
15.6.3.3. Geographical Revenue, 2019
15.6.4. Product Offerings
15.6.5. Recent Initiatives (2017-2019)
15.7. Galderma S.A.
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Performance (2015-2019)
15.7.3.1. Net Revenue
15.7.3.2. Gross Profit
15.7.3.3. Geographical Revenue, 2019
15.7.4. Product Offerings
15.7.5. Recent Initiatives (2017-2019)
15.8. OASIS Medical
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Performance (2015-2019)
15.8.3.1. Net Revenue
15.8.3.2. Gross Profit
15.8.3.3. Geographical Revenue, 2019
15.8.4. Product Offerings
15.8.5. Recent Initiatives (2017-2019)
15.9. AFT Pharmaceuticals
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Performance (2015-2019)
15.9.3.1. Net Revenue
15.9.3.2. Gross Profit
15.9.3.3. Geographical Revenue, 2019
15.9.4. Product Offerings
15.9.5. Recent Initiatives (2017-2019)
15.10. I-Med Pharma Inc.
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Performance (2015-2019)
15.10.3.1. Net Revenue
15.10.3.2. Gross Profit
15.10.3.3. Geographical Revenue, 2019
15.10.4. Product Offerings
15.10.5. Recent Initiatives (2017-2019)
15.11. Other Notable Players
16. Conclusion
17. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Periodontal Therapeutics Market Drivers & Restraints 2021
Table 7. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 173. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 268. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 269. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 270. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 271. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 272. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 273. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 274. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 275. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 276. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 277. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 278. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 279. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 280. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 281. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 282. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 283. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 284. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 285. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 286. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 287. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 288. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 289. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 290. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 291. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 292. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 293. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 294. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 295. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 296. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 297. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 298. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 299. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 300. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 301. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 302. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 303. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 304. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 305. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 306. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 307. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 308. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 309. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 310. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 311. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 312. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 313. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 314. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 315. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 316. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 317. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 318. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 319. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 320. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 321. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 322. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 323. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 324. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 325. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 326. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 327. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 328. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 329. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 330. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 331. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 332. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 333. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 334. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 335. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 336. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 337. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 338. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 339. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 340. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 341. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 342. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 343. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 344. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 345. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 346. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 347. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 348. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 349. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 350. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 351. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 352. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 353. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 354. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 355. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 356. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 357. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 358. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 359. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 360. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 361. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 362. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 363. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 364. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 365. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 366. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 367. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 368. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 369. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 370. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 371. Leading 10 Periodontal Therapeutics Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 372. Den-Mat Holdings, LLCProfile 2019 (CEO, HQ, Founded, Website)
Table 373. Den-Mat Holdings, LLC Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 374. Valeant Pharmaceuticals International, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 375. Valeant Pharmaceuticals International, Inc. Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 376. DEXCEL PHARMA Profile 2019 (CEO, HQ, Founded, Website)
Table 377. DEXCEL PHARMA.Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 378. 3M Company Profile 2019 (CEO, HQ, Founded, Website)
Table 379. 3M Company Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 380. Oral Science Profile 2019 (CEO, HQ, Founded, Website)
Table 381. Oral Science Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 382. Kaken Pharmaceutical Co., Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 383. Kaken Pharmaceutical Co., Ltd. Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 384. Galderma S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 385. Galderma S.A. Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 386. OASIS Medical Profile 2019 (CEO, HQ, Founded, Website)
Table 387. OASIS Medical Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 388. AFT Pharmaceuticals Profile 2019 (CEO, HQ, Founded, Website)
Table 389. AFT Pharmaceuticals Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 390. I-Med Pharma Inc. Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 391. I-Med Pharma Inc. Periodontal Therapeutics Product Offering (Segment, Product Offerings)
Table 392. Other Companies Involved in the Periodontal Therapeutics Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Periodontal Therapeutics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Periodontal Therapeutics Market Drivers & Restraints 2021
Figure 7. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Systemic Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Local Antibiotics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Gingivitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. Chronic Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. Aggressive Periodontitis Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. Necrotizing Periodontal Disease Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Geriatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Adults Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Pediatric Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Generic Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Branded Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 118. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 123. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. North America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. North America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 138. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. North America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 143. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. North America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. North America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. North America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 158. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. North America Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. US Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Canada Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 173. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Europe Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Europe Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 183. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 184. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 185. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 186. Europe Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 187. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 188. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 189. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 190. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 191. Europe Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 192. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 193. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 194. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 195. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 196. Europe Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 197. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 198. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 199. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 200. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 201. Europe Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 202. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. Europe Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 207. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. UK Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 212. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Germany Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. France Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Rest of Europe Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. Asia Pacific Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Asia Pacific Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. Asia Pacific Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. Asia Pacific Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Asia Pacific Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. Asia Pacific Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Asia Pacific Periodontal Therapeutics Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. China Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 268. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 269. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 270. India Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 271. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 272. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 273. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 274. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 275. Japan Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 276. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 277. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 278. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 279. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 280. RoAPAC Periodontal Therapeutics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 281. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 282. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 283. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 284. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 285. Middle East Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 286. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 287. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 288. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 289. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 290. Middle East Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 291. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 292. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 293. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 294. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 295. Middle East Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 296. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 297. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 298. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 299. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 300. Middle East Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 301. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 302. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 303. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 304. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 305. Middle East Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 306. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 307. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 308. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 309. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 310. Middle East Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 311. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 312. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 313. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 314. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 315. Latin America Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 316. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 317. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 318. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 319. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 320. Latin America Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 321. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 322. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 323. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 324. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 325. Latin America Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 326. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 327. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 328. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 329. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 330. Latin America Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 331. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 332. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 333. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 334. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 335. Latin America Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 336. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 337. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 338. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 339. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 340. Latin America Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 341. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 342. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 343. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 344. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 345. Africa Periodontal Therapeutics Market Forecast By Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 346. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 347. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 348. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 349. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 350. Africa Periodontal Therapeutics Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 351. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 352. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 353. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 354. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 355. Africa Periodontal Therapeutics Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 356. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 357. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 358. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 359. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 360. Africa Periodontal Therapeutics Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 361. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 362. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 363. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 364. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 365. Africa Periodontal Therapeutics Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 366. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 367. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 368. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 369. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 370. Africa Periodontal Therapeutics Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 371. Porter’s Five Force Analysis
Companies Mentioned
1. AbbVie
2. Achaogen
3. Actavis
4. Actelion
5. Affinium Pharmaceutical
6. AiCuris GmbH & Co. KG
7. Alcon
8. Alkem Laboratories
9. Dexcel Pharma
10. Allied Pharma
11. Apotex
12. APP Pharmaceuticals
13. Aptalis Pharma
14. Aquapharm Biodiscovery
15. Cempra Pharmaceuticals
16. Cipla
17. Claris Lifesciences
18. Cornerstone Biopharma
19. Cornerstone Therapeutics
20. Corona Remedies
21. Eli Lilly
22. Gate Pharma
23. Gilead Sciences
24. GlaxoSmithKline (GSK)
25. Glenmark
26. GlycoVaxyn
27. Hetero
28. Hikma Farmaceutica
29. Hi-Tech Pharma
30. Hospira
31. Macleod Pharmaceuticals
32. Microlabs
33. Nalneva
34. Novartis
35. Novexel
36. Paratek Pharmaceuticals
37. Pfizer
38. Ranbaxy
39. Roche
40. Sagent Pharmaceuticals
41. Sandoz
42. Sanofi
43. Sequella
44. Shanghai MengKe Pharmaceuticals
45. Shionogi
46. SHIONOGI Co., Ltd.
47. Shire
48. Sidmak Labs
49. Solitaire Pharmacia
50. Specialised Therapeutics Australia
Companies Profiled in the Report
1. Den-Mat Holdings, LLC
2. Valeant Pharmaceuticals International, Inc.
3. Dexcel Pharma
4. 3M Company
5. Oral Science
6. Kaken Pharmaceutical Co., Ltd.
7. Galderma S.A.
8. OASIS Medical
9. AFT Pharmaceuticals
10. I-Med Pharma Inc.
11. Dentsply Sirona
12. Biohorizons
13. Zimmer Biomet
14. Emergent Biosolutions, Inc.
15. F. Hoffmann-La Roche Ltd.
List of Companies Mentioned in the Report:
1. AbbVie
2. Achaogen
3. Actavis
4. Actelion
5. Affinium Pharmaceutical
6. AiCuris GmbH & Co. KG
7. Alcon
8. Alkem Laboratories
9. Allergan
10. Allied Pharma
11. Apotex
12. APP Pharmaceuticals
13. Aptalis Pharma
14. Aquapharm Biodiscovery
15. Cempra Pharmaceuticals
16. Cipla
17. Claris Lifesciences
18. Cornerstone Biopharma
19. Cornerstone Therapeutics
20. Corona Remedies
21. Eli Lilly
22. Gate Pharma
23. Gilead Sciences
24. GlaxoSmithKline (GSK)
25. Glenmark
26. GlycoVaxyn
27. Hetero
28. Hikma Farmaceutica
29. Hi-Tech Pharma
30. Hospira
31. Macleod Pharmaceuticals
32. Microlabs
33. Nalneva
34. Novartis
35. Novexel
36. Paratek Pharmaceuticals
37. Pfizer
38. Ranbaxy
39. Roche
40. Sagent Pharmaceuticals
41. Sandoz
42. Sanofi
43. Sequella
44. Shanghai MengKe Pharmaceuticals
45. Shionogi
46. SHIONOGI Co., Ltd.
47. Shire
48. Sidmak Labs
49. Solitaire Pharmacia
50. Specialised Therapeutics Australia
List of Organizations Mentioned in the Report:
1. Centre for Pharmaceutical Administration Health Sciences Authority
2. Central Drug Standard Control Organization (CDSCO)
3. Organisation for Economic Co-operation and Development (OECD)
4. European Medicines Agency (EMA)
5. Food and Drug Administration (FDA)
6. National Institutes of Health (NIH)
7. United Nations (UN)
8. United Nations Office on Drugs and Crime (UNODC)
9. United Nations Statistics Division (UNSD)
10. Statistical Office of the European Union (EUROSTAT)
11. University of Connecticut
12. World Health Organization (WHO)
13. The National Medical Products Administration (NMPA)
14. Indian Council of Medical Research (ICMR)
15. The Therapeutic Goods Administration
16. The Federal Institute for Drugs and Medical Devices (BfArM)
17. Pharmaceuticals and Medical Devices Agency (PMDA)
18. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
19. Ministry of Health, Labour & Welfare(MHLW)
20. Medicines and Healthcare Products Regulatory Agency (MHRA)
1. Den-Mat Holdings, LLC
2. Valeant Pharmaceuticals International, Inc.
3. Dexcel Pharma
4. 3M Company
5. Oral Science
6. Kaken Pharmaceutical Co., Ltd.
7. Galderma S.A.
8. OASIS Medical
9. AFT Pharmaceuticals
10. I-Med Pharma Inc.
11. Dentsply Sirona
12. Biohorizons
13. Zimmer Biomet
14. Emergent Biosolutions, Inc.
15. F. Hoffmann-La Roche Ltd.
List of Companies Mentioned in the Report:
1. AbbVie
2. Achaogen
3. Actavis
4. Actelion
5. Affinium Pharmaceutical
6. AiCuris GmbH & Co. KG
7. Alcon
8. Alkem Laboratories
9. Allergan
10. Allied Pharma
11. Apotex
12. APP Pharmaceuticals
13. Aptalis Pharma
14. Aquapharm Biodiscovery
15. Cempra Pharmaceuticals
16. Cipla
17. Claris Lifesciences
18. Cornerstone Biopharma
19. Cornerstone Therapeutics
20. Corona Remedies
21. Eli Lilly
22. Gate Pharma
23. Gilead Sciences
24. GlaxoSmithKline (GSK)
25. Glenmark
26. GlycoVaxyn
27. Hetero
28. Hikma Farmaceutica
29. Hi-Tech Pharma
30. Hospira
31. Macleod Pharmaceuticals
32. Microlabs
33. Nalneva
34. Novartis
35. Novexel
36. Paratek Pharmaceuticals
37. Pfizer
38. Ranbaxy
39. Roche
40. Sagent Pharmaceuticals
41. Sandoz
42. Sanofi
43. Sequella
44. Shanghai MengKe Pharmaceuticals
45. Shionogi
46. SHIONOGI Co., Ltd.
47. Shire
48. Sidmak Labs
49. Solitaire Pharmacia
50. Specialised Therapeutics Australia
List of Organizations Mentioned in the Report:
1. Centre for Pharmaceutical Administration Health Sciences Authority
2. Central Drug Standard Control Organization (CDSCO)
3. Organisation for Economic Co-operation and Development (OECD)
4. European Medicines Agency (EMA)
5. Food and Drug Administration (FDA)
6. National Institutes of Health (NIH)
7. United Nations (UN)
8. United Nations Office on Drugs and Crime (UNODC)
9. United Nations Statistics Division (UNSD)
10. Statistical Office of the European Union (EUROSTAT)
11. University of Connecticut
12. World Health Organization (WHO)
13. The National Medical Products Administration (NMPA)
14. Indian Council of Medical Research (ICMR)
15. The Therapeutic Goods Administration
16. The Federal Institute for Drugs and Medical Devices (BfArM)
17. Pharmaceuticals and Medical Devices Agency (PMDA)
18. Agencia Nacional de Vigiloncia Sanitaria (ANVISA )
19. Ministry of Health, Labour & Welfare(MHLW)
20. Medicines and Healthcare Products Regulatory Agency (MHRA)
Download sample pages
Complete the form below to download your free sample pages for Periodontal Therapeutics Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Periodontal Therapeutics Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.
10 March 2023
